Lacosamide fda approval date?

Lacosamide (brand Vimpat) was approved by the FDA on March 26, 2008, as an adjunctive therapy for adults with partial-onset seizures. It later received additional indications and formulation approvals. If you’d like, I can share the official FDA press release or provide more details on later approvals.